International Patent: ANTI-ADAM9 ANTIBODIES AND USES THEREOF

GENEVA, Aug. 31 -- BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. filed a patent application (CN2026/078373) for “ANTI-ADAM9 ANTIBODIES AND USES THEREOF”. With publication no. WO/2026/175263, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/40

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....